INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.
Clinical trial NCT01493414 · COMPLETED
Trial details
- NCT number
- NCT01493414
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-16
- Primary completion
- 2017-01-26
- Enrollment
- 2233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.